Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.02 | - |
NAV | ₹10.60 | - |
Fund Started | 06 May 2025 | - |
Fund Size | ₹2307.94 Cr | - |
Exit Load | Exit load of 1%, if redeemed within 12 months.
| - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | - | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 92.88% | - |
Cash | 5.39% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Infosys Ltd. | 7.55% |
Sun Pharmaceutical Industries Ltd. | 6.40% |
SBI Life Insurance Company Ltd. | 3.73% |
Alkem Laboratories Ltd. | 3.52% |
Tata Consultancy Services Ltd. | 3.37% |
Hindustan Unilever Ltd. | 3.13% |
HDFC Bank Ltd. | 3.06% |
ITC Ltd. | 2.80% |
Astrazeneca Pharma India Ltd. | 2.30% |
Info Edge (India) Ltd. | 2.19% |
Name | Ihab Dalwai | - |
Start Date | 06 May 2025 | - |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investing in Equity & Equity related instruments of companies identified based on the Quality Factor. | - |
Launch Date | 06 May 2025 | - |
Description
Launch Date